---
layout: post
title: "东北制药：原料药左乙拉西坦通过CDE审批"
date: 2021-12-19 17:46:36 +0800
categories: zhengquanshibao
tags: 证券时报新闻
---
<p style="display:none;height:1px;overflow:hidden;"><br /></p><!-- EM_StockImg_Start --><p style="text-align:center;"><a href="http://quote.eastmoney.com/unify/r/0.000597" data-code="000597|0|2" data-code2="000597|0|6|" class="EmImageRemark" target="_blank"><img src="https://webquoteklinepic.eastmoney.com/GetPic.aspx?nid=0.000597&imageType=k&token=28dfeb41d35cc81d84b4664d7c23c49f&at=1" border="0" alt="K图 000597_0" data-code="K 000597|0|2" data-code2="K 000597|0|6|" style="border:#d1d1d1 1px solid;" width="578" height="276" /></a></p><!-- EM_StockImg_End --><p>东北制药(000597)12月19日晚间公告，原料药左乙拉西坦通过CDE审批。 <br /></p><p class="em_media">（文章来源：证券时报）</p>

<http://choicewzp1.eastmoney.com/html_News/NewsShare.html?infoCode=NW202112192218641161>

[返回证券时报新闻](//finews.withounder.com/category/zhengquanshibao.html)｜[返回首页](//finews.withounder.com/)